MedPath

RESILIENCE GOVERNMENT SERVICES, INC.

RESILIENCE GOVERNMENT SERVICES, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
1999-01-01
Employees
251
Market Cap
-
Website
https://www.ologybio.com

Clinical Trials

37

Active:0
Completed:35

Trial Phases

4 Phases

Phase 1:15
Phase 2:6
Phase 3:13
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (36 trials with phase data)• Click on a phase to view related trials

Phase 1
15 (41.7%)
Phase 3
13 (36.1%)
Phase 2
6 (16.7%)
Not Applicable
2 (5.6%)

Evaluating Technologies for Point-of-Care Blood Collections by Patients

Not Applicable
Completed
Conditions
Healthy
First Posted Date
2024-07-18
Last Posted Date
2025-04-08
Lead Sponsor
Resilience Government Services, Inc.
Target Recruit Count
200
Registration Number
NCT06507566
Locations
🇺🇸

Victor Salib, Riverside, California, United States

Single or Repeat Dose of G03-52-01 in Adult Subjects

Phase 2
Completed
Conditions
Healthy
Botulinum Toxin
Interventions
Drug: Placebo
First Posted Date
2022-04-27
Last Posted Date
2025-02-11
Lead Sponsor
Resilience Government Services, Inc.
Target Recruit Count
625
Registration Number
NCT05348993
Locations
🇺🇸

AMR Mobile, Mobile, Alabama, United States

🇺🇸

AMR Tempe, Tempe, Arizona, United States

🇺🇸

AMR Fort Myers, Fort Myers, Florida, United States

and more 12 locations

Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19

Phase 2
Withdrawn
Conditions
COVID-19
Interventions
Other: Placebo
First Posted Date
2021-12-02
Last Posted Date
2023-02-03
Lead Sponsor
Resilience Government Services, Inc.
Registration Number
NCT05142527

Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)

Phase 3
Withdrawn
Conditions
Mild to Moderate COVID-19
Interventions
Drug: Placebo
First Posted Date
2021-01-12
Last Posted Date
2022-03-03
Lead Sponsor
Resilience Government Services, Inc.
Registration Number
NCT04705844

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

Phase 1
Completed
Conditions
SARS-CoV-2
Interventions
Other: Placebo
First Posted Date
2020-10-19
Last Posted Date
2025-03-07
Lead Sponsor
Resilience Government Services, Inc.
Target Recruit Count
48
Registration Number
NCT04592549
Locations
🇺🇸

PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, United States

🇺🇸

ICON Early Phase Services, LLC, San Antonio, Texas, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.